{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:03:59Z","timestamp":1791338639184,"version":"4.3.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T00:00:00Z","timestamp":1639440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Endemic Burkitt lymphoma (eBL) is the most common childhood cancer in regions of equatorial Africa where <jats:italic>P. falciparum<\/jats:italic> malaria is holoendemic. The tumor is consistently associated with Epstein-Barr virus (EBV). Screening for EBV DNA in plasma in a high-risk population in Hong Kong has been shown to be useful in facilitating the early diagnosis of nasopharyngeal carcinoma, another EBV-associated tumor. Here, we investigate plasma EBV as a diagnostic marker for eBL in children in Uganda. We studied plasma specimens from 25 children with eBL and 25 controls matched for age (&amp;lt;3-16 years), gender and geography, including many with asymptomatic <jats:italic>P. falciparum<\/jats:italic> infection. These specimens were previously collected under the auspices of the EMBLEM (Epidemiology of Burkitt lymphoma in East African children and minors) study. After cell-free DNA isolation, plasma EBV DNA was measured using a quantitative PCR assay that amplifies the large internal repeats of the EBV genome. All children with eBL had measurable plasma EBV, as compared to 84% of control children. The median plasma EBV DNA level was 5.23 log<jats:sub>10<\/jats:sub> copies\/mL (interquartile range 3.54-6.08 log<jats:sub>10<\/jats:sub> copies\/mL) in children with eBL. In contrast, the median plasma EBV DNA level was 0.37 log<jats:sub>10<\/jats:sub> copies\/mL (interquartile range 0.18-1.05 log<jats:sub>10<\/jats:sub> copies\/mL) in children without lymphoma. An EBV threshold of 2.52 log<jats:sub>10<\/jats:sub> copies\/mL yielded a sensitivity of.88 and a specificity of 1. The estimated AUC was 0.936 (95% CI: 0.8496 \u2013 1.00) for the corresponding ROC curve. Plasma EBV copy number did not depend on age, gender, or malaria screening status. However, two control children with asymptomatic <jats:italic>P. falciparum<\/jats:italic> infection and parasitemia also had high plasma EBV copy number. Our analysis suggests that measurements of EBV copy number in plasma may be useful in identifying children with eBL versus control children. A promising area for future research is the differentiation of high copy number associated with tumor versus high copy number associated with asymptomatic parasitemia.<\/jats:p>","DOI":"10.3389\/fonc.2021.804083","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T11:51:49Z","timestamp":1639482709000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt Lymphoma"],"prefix":"10.3389","volume":"11","author":[{"given":"Rena R.","family":"Xian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Kinyera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Otim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua N.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadijah","family":"Nabalende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail D.","family":"Legason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin D.","family":"Ogwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Kerchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishor","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Goedert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam M.","family":"Mbulaiteye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Ambinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(64)92354-2","article-title":"Cultivation In Vitro of Human Lymphoblasts From Burkitt\u2019s Malignant Lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus Particles in Cultured Lymphoblasts From Burkitt\u2019s Lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32390","article-title":"Risk Factors for Burkitt Lymphoma in East African Children and Minors: A Case\u2013Control Study in Malaria-Endemic Regions in Uganda, Tanzania and Kenya","volume":"146","author":"Peprah","year":"2020","journal-title":"Int J Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-019-0236-7","article-title":"The Burden of Burkitt Lymphoma in Africa","volume":"14","author":"H\u00e4mmerl","year":"2019","journal-title":"Infect Agents Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/apm.13018","article-title":"Endemic Burkitt Lymphoma\u2013An Aggressive Childhood Cancer Linked to Plasmodium Falciparum Exposure, But Not to Exposure to Other Malaria Parasites","volume":"128","author":"Quintana","year":"2020","journal-title":"Apmis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ebiom.2018.12.041","article-title":"Epstein-Barr Virus, Malaria and Endemic Burkitt Lymphoma","volume":"39","author":"Velavan","year":"2019","journal-title":"EBioMedicine"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2007.01875.x","article-title":"Spatial Distribution of Burkitt\u2019s Lymphoma in Kenya and Association With Malaria Risk","volume":"12","author":"Rainey","year":"2007","journal-title":"Trop Med Int Health"},{"key":"B8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal Carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1701717","article-title":"Analysis of Plasma Epstein\u2013Barr Virus DNA to Screen for Nasopharyngeal Cancer","volume":"377","author":"Chan","year":"2017","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1086\/500839","article-title":"Clearance of Circulating Epstein-Barr Virus DNA in Children With Acute Malaria After Antimalaria Treatment","volume":"193","author":"Donati","year":"2006","journal-title":"J Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28378","article-title":"Sickle Cell Trait Is Not Associated With Endemic Burkitt Lymphoma: An Ethnicity and Malaria Endemicity-Matched Case\u2013Control Study Suggests Factors Controlling EBV May Serve as a Predictive Biomarker for This Pediatric Cancer","volume":"134","author":"Mulama","year":"2014","journal-title":"Int J Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30682","article-title":"Plasma Epstein-Barr Virus DNA for Pediatric Burkitt Lymphoma Diagnosis, Prognosis and Response Assessment in Malawi","volume":"140","author":"Westmoreland","year":"2017","journal-title":"Int J Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00377","article-title":"Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial","volume":"39","author":"Frank","year":"2021","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2008.080023","article-title":"Laboratory Assays for Epstein-Barr Virus-Related Disease","volume":"10","author":"Gulley","year":"2008","journal-title":"J Mol Diagn"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aan2415","article-title":"Direct Detection of Early-Stage Cancers Using Circulating Tumor DNA","volume":"9","author":"Phallen","year":"2017","journal-title":"Sci Transl Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-018-2379-1","article-title":"A Cross-Sectional Study of Asymptomatic Plasmodium Falciparum Infection Burden and Risk Factors in General Population Children in 12 Villages in Northern Uganda","volume":"17","author":"Maziarz","year":"2018","journal-title":"Malaria J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-017-1778-z","article-title":"Age and Geographic Patterns of Plasmodium Falciparum Malaria Infection in a Representative Sample of Children Living in Burkitt Lymphoma-Endemic Areas of Northern Uganda","volume":"16","author":"Maziarz","year":"2017","journal-title":"Malaria J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-09-454694","article-title":"Plasma Epstein-Barr Virus DNA Predicts Outcome in Advanced Hodgkin Lymphoma: Correlative Analysis From a Large North American Cooperative Group Trial","volume":"121","author":"Kanakry","year":"2013","journal-title":"Blood"},{"key":"B19","article-title":"R: A Language and Environment for Statistical Computing","volume-title":"R Foundation for Statistical Computing","year":"2017"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-844472","article-title":"How I Treat Burkitt Lymphoma in Children, Adolescents, and Young Adults in Sub-Saharan Africa","volume":"132","author":"Gopal","year":"2018","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002178","article-title":"Five Decades of Low Intensity and Low Survival: Adapting Intensified Regimens to Cure Pediatric Burkitt Lymphoma in Africa","volume":"4","author":"Ozuah","year":"2020","journal-title":"Blood Adv"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e27813","DOI":"10.1002\/pbc.27813","article-title":"Survival of Children With Endemic Burkitt Lymphoma in a Prospective Clinical Care Project in Uganda","volume":"66","author":"McGoldrick","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32053","article-title":"Cancer Incidence in Northern Uganda (2013\u20132016)","volume":"144","author":"Okongo","year":"2019","journal-title":"Int J Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1706815","article-title":"Plasma Epstein\u2013Barr Virus DNA for Screening","volume":"377","author":"Ambinder","year":"2017","journal-title":"N Engl J Med"},{"key":"B25","first-page":"239","article-title":"Detection and Characterization of Epstein-Barr Virus in Clinical Specimens","volume":"145","author":"Ambinder","year":"1994","journal-title":"Am J Pathol"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-62703-357-2_16","article-title":"EBER In Situ Hybridization for Epstein\u2013Barr Virus","volume-title":"Hematological Malignancies","author":"Weiss","year":"2013"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1691","article-title":"The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA","volume":"23","author":"Parpart-Li","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0166354","DOI":"10.1371\/journal.pone.0166354","article-title":"Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing","volume":"11","author":"Medina Diaz","year":"2016","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001511","article-title":"CpG Methylation in Cell-Free Epstein-Barr Virus DNA in Patients With EBV-Hodgkin Lymphoma","volume":"4","author":"Shamay","year":"2020","journal-title":"Blood Adv"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.3390\/cancers12082166","article-title":"Lymphotropic Viruses EBV, KSHV and HTLV in Latin America: Epidemiology and Associated Malignancies. A Literature-Based Study by the RIAL-CYTED","volume":"12","author":"Chabay","year":"2020","journal-title":"Cancers"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.804083\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T11:51:54Z","timestamp":1639482714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.804083\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,14]]},"references-count":30,"alternative-id":["10.3389\/fonc.2021.804083"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.804083","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,14]]},"article-number":"804083"}}